Primary mediastinal large B-cell lymphoma segregating in a family: Exome sequencing identifies MLL as a candidate predisposition gene

Blood

Volumn 121, Issue 17, 2013, Pages 3428-3430

  Saarinen, Silva ^a   Kaasinen, Eevi ^a   Karjalainen Lindsberg, Marja Liisa ^a,b   Vesanen, Kari ^a   Aavikko, Mervi ^a   Katainen, Riku ^a   Taskinen, Minna ^a,b   Kytölä, Soili ^b   Leppä, Sirpa ^a,b   Hietala, Marja ^c,d   Vahteristo, Pia ^a   Aaltonen, Lauri A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MIXED LINEAGE LEUKEMIA PROTEIN; PROTEIN BCL 2; MLL PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DIFFUSE LARGE B CELL LYMPHOMA; DISEASE PREDISPOSITION; FATIGUE; FEMALE; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GERMINAL CENTER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPE; LARGE CELL LYMPHOMA; LINKAGE ANALYSIS; LIVER DISEASE; LYMPHADENOPATHY; MALE; MEDIASTINUM MASS; MEDIASTINUM TUMOR; PRIORITY JOURNAL; TUMOR BIOPSY; WEIGHT REDUCTION; WHOLE EXOME SEQUENCING; WHOLE GENOME SEQUENCING; ADULT; EXOME; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETICS; HIGH THROUGHPUT SEQUENCING; MIDDLE AGED; PEDIGREE;

ADULT; EXOME; FEMALE; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; MYELOID-LYMPHOID LEUKEMIA PROTEIN; PEDIGREE;

MLCS; MLOWN;

EID: 84879352608     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-06-437210     Document Type: Article

References (14)

1. Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: International Agency for Research on Cancer; 2008
2. Skibola CF, Curry JD, Nieters A. Genetic susceptibility to lymphoma. Haematologica. 2007; 92(7):960-969.
3. Goldin LR, Björkholm M, Kristinsson SY, Turesson I, Landgren O. Highly increased familial risks for specific lymphoma subtypes. Br J Haematol. 2009;146(1):91-94.
4. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin - rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet. 2002; 30(1):97-101.
5. Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4): 248-249.
6. Wootton JC. Non-globular domains in protein sequences: automated segmentation using complexity measures. Comput Chem. 1994;18(3): 269-285.
7. Wan H, Wootton JC. A global compositional complexity measure for biological sequences: AT-rich and GC-rich genomes encode less complex proteins. Comput Chem. 2000;24(1):71-94.
8. Finn RD, Mistry J, Tate J, et al. The Pfam protein families database. Nucleic Acids Res. 2010; 38(Database issue):D211-D222.
9. Sigrist CJA, Cerutti L, de Castro E, et al. PROSITE, a protein domain database for functional characterization and annotation. Nucleic Acids Res. 2010;38(Database issue): D161-D166.
10. Kay BK, Williamson MP, Sudol M. The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J. 2000;14(2):231-241.
11. Wang J, Muntean AG, Hess JL. ECSASB2 mediates MLL degradation during hematopoietic differentiation. Blood. 2012;119(5):1151-1161.
12. Liedtke M, Cleary ML. Therapeutic targeting of MLL. Blood. 2009;113(24):6061-6068.
13. Morin RD, Mendez-Lago M, Mungall AJ, et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature. 2011;476(7360): 298-303.
14. Pasqualucci L, Trifonov V, Fabbri G, et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet. 2011;43(9): 830-837.